
Sign up to save your podcasts
Or


Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Pfizer3
11 ratings
Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

85 Listeners

3,723 Listeners

1,920 Listeners

393 Listeners

133 Listeners

140 Listeners

113 Listeners

918 Listeners

27 Listeners

92 Listeners

14 Listeners

797 Listeners

174 Listeners

650 Listeners

139 Listeners

0 Listeners

1,092 Listeners

94 Listeners

0 Listeners

0 Listeners

8 Listeners